Log In
BCIQ
Print this Print this
 

Dyloject, diclofenac sodium

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionNon-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenases (COX)
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to severe postoperative pain; Treat pain; Treat postoperative pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$2,032.7M

$1,950.0M

$59.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today